WallStreetZenWallStreetZen

NYSE: OSCR
OSCAR HEALTH INC Stock Forecast, Predictions & Price Target

Analyst price target for OSCR

Based on 4 analysts offering 12 month price targets for OSCAR HEALTH INC.
Min Forecast
$9.00+89.87%
Avg Forecast
$13.50+184.81%
Max Forecast
$26.00+448.52%

Should I buy or sell OSCR stock?

Based on 4 analysts offering ratings for OSCAR HEALTH INC.
Buy
Strong Buy
1 analysts 25%
Buy
1 analysts 25%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

OSCR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Anonymous
Morgan Stanley
Strong BuyMaintains$18.00+279.75%2022-03-28
Goldman Sachs
Bottom 14%
14
HoldUpgrades$9.00+89.87%2022-02-14
Credit Suisse
Bottom 7%
7
BuyMaintains$10.00+110.97%2022-01-07
Wells Fargo
Bottom 7%
7
HoldDowngrades$9.00+89.87%2022-01-06
Morgan Stanley
Bottom 27%
27
Strong BuyMaintains$26.00+448.52%2021-08-31

1 of 1

Forecast return on equity

Is OSCR forecast to generate an efficient return?
Company
-11.25%
Industry
28.82%
Market
38.98%
OSCR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OSCR forecast to generate an efficient return on assets?
Company
-3.44%
Industry
9.5%
OSCR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OSCR earnings per share forecast

What is OSCR's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$2.54
Avg 2 year Forecast
-$1.49
Avg 3 year Forecast
-$0.71

OSCR revenue forecast

What is OSCR's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$3.5B+44.45%
Avg 2 year Forecast
$4.4B+79.89%
Avg 3 year Forecast
$4.5B+85.9%
OSCR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OSCR revenue growth forecast

How is OSCR forecast to perform vs Healthcare Plans companies and vs the US market?
Company
30.95%
Industry
6.71%
Market
8.09%
OSCR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OSCR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OSCR vs Healthcare Plan Stocks

TickerPricePrice TargetUp/downsideConsensus
OSCR$4.74$13.50+184.81%Buy
BHG$1.80$10.54+485.67%Buy
CLOV$2.57$6.20+141.25%Hold
ALHC$10.39$21.38+105.73%Strong Buy
MRAI$1.43N/AN/A

OSCAR HEALTH Stock Forecast FAQ

Is OSCAR HEALTH Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: OSCR) stock is to Buy OSCR stock.

Out of 4 analysts, 1 (25%) are recommending OSCR as a Strong Buy, 1 (25%) are recommending OSCR as a Buy, 2 (50%) are recommending OSCR as a Hold, 0 (0%) are recommending OSCR as a Sell, and 0 (0%) are recommending OSCR as a Strong Sell.

What is OSCR's earnings growth forecast for 2022-2024?

(NYSE: OSCR) OSCAR HEALTH's forecast annual earnings growth rate of N/A is not forecast to beat the US Healthcare Plans industry's average forecast earnings growth rate of 19.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.32%.

OSCAR HEALTH's earnings in 2022 is -$560,387,000.On average, 2 Wall Street analysts forecast OSCR's earnings for 2022 to be -$535,958,174, with the lowest OSCR earnings forecast at -$582,379,748, and the highest OSCR earnings forecast at -$489,536,600. On average, 2 Wall Street analysts forecast OSCR's earnings for 2023 to be -$314,400,661, with the lowest OSCR earnings forecast at -$365,042,378, and the highest OSCR earnings forecast at -$261,648,872.

In 2024, OSCR is forecast to generate -$149,815,080 in earnings, with the lowest earnings forecast at -$149,815,080 and the highest earnings forecast at -$149,815,080.

What is OSCR's revenue growth forecast for 2022-2024?

(NYSE: OSCR) OSCAR HEALTH's forecast annual revenue growth rate of 30.95% is forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 6.71%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.09%.

OSCAR HEALTH's revenue in 2022 is $2,442,092,000.On average, 2 Wall Street analysts forecast OSCR's revenue for 2022 to be $744,364,665,515, with the lowest OSCR revenue forecast at $650,568,820,010, and the highest OSCR revenue forecast at $838,160,511,019. On average, 2 Wall Street analysts forecast OSCR's revenue for 2023 to be $926,992,413,203, with the lowest OSCR revenue forecast at $840,838,191,816, and the highest OSCR revenue forecast at $1,013,146,634,589.

In 2024, OSCR is forecast to generate $957,949,272,913 in revenue, with the lowest revenue forecast at $957,949,272,913 and the highest revenue forecast at $957,949,272,913.

What is OSCR's forecast return on assets (ROA) for 2022-2024?

(NYSE: OSCR) forecast ROA is -3.44%, which is lower than the forecast US Healthcare Plans industry average of 9.5%.

What is OSCR's Price Target?

According to 4 Wall Street analysts that have issued a 1 year OSCR price target, the average OSCR price target is $13.50, with the highest OSCR stock price forecast at $26.00 and the lowest OSCR stock price forecast at $9.00.

On average, Wall Street analysts predict that OSCAR HEALTH's share price could reach $13.50 by Feb 14, 2023. The average OSCAR HEALTH stock price prediction forecasts a potential upside of 184.81% from the current OSCR share price of $4.74.

What is OSCR's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: OSCR) OSCAR HEALTH's current Earnings Per Share (EPS) is -$2.72. On average, analysts forecast that OSCR's EPS will be -$2.54 for 2022, with the lowest EPS forecast at -$2.76, and the highest EPS forecast at -$2.32. On average, analysts forecast that OSCR's EPS will be -$1.49 for 2023, with the lowest EPS forecast at -$1.73, and the highest EPS forecast at -$1.24. In 2024, OSCR's EPS is forecast to hit -$0.71 (min: -$0.71, max: -$0.71).

What is OSCR's forecast return on equity (ROE) for 2022-2024?

(NYSE: OSCR) forecast ROE is -11.25%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.